G. Wilson

Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer.

J. Chester, M. Seymour, J. Dent, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

A feasibility, pharmacokinetic and frequency-escalation trial of intraperitoneal chemotherapy in high risk gastrointestinal tract cancer.

S. Joel, M. Slevin, J. Chester, 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.

N. Stambler, R. Portenoy, A. Lipman, 2009, The journal of supportive oncology.

A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications

P. Corrie, A. M. Moody, D. Parashar, 2012, British Journal of Cancer.

Epirubicin, cisplatin and oral UFT with leucovorin ('ECU'): a phase I-II study in patients with advanced upper gastrointestinal tract cancer.

M. Slevin, M. Seymour, D. Papamichael, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma.

A. Dalgleish, S. Mudan, J. Stebbing, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

A ‘modified de Gramont’ regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer

S. Joel, J. Chester, M. Seymour, 2002, British Journal of Cancer.